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Background: We aimed to develop a mouse spontaneous liver metastasis model from an orthotopically implanted
human colon cancer cell line stably expressing a human sodium/iodide symporter (NIS) reporter gene, which can
be imaged with single-photon emission computed tomography (SPECT) using 99mTcO4
−.
Methods: A recombinant plasmid containing a constitutively driven NIS gene (pcDNA3-NIS) was transfected into
the human colon cancer cell line HCT116, and stable cell lines were established. The stable cells were
subcutaneously injected into the nude mice. When the diameter reached 10 mm, the xenografts were excised, cut
into small fragments, and orthotopically implanted into the cecal walls of another nude mice. 99mTcO4
− SPECT/CT
imaging was initiated 8 weeks later and repeated every 1 to 2 weeks.
Results: The production and function of NIS protein was confirmed in vitro by Western blotting
and 99mTcO4
− uptake assay. On SPECT/CT imaging, focal 99mTcO4
− uptake was detected in the liver. Necropsy
revealed local growth of the orthotopic colon xenografts with extensive invasion, microscopic serosal metastasis,
and metastatic foci in the corresponding hepatic regions showing focal 99mTcO4
− uptake. Immunohistochemistry
revealed high levels of NIS expression in cells forming liver tumor, indicating that the liver tumor cells originated
from the orthotopic colon xenografts.
Conclusions: The present proof-of-concept study provided a rationale for employing a radionuclide reporter gene
for the specific visualization of spontaneous liver metastasis in living mice. This unique animal model of clinically
relevant and externally detectable liver metastasis will be a powerful tool for investigating tumor biology and
developing novel therapies for cancer metastasis.
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Research using animal models that represent all pro-
cesses of metastasis formation is essential. However, the
currently used rodent tumor models, such as the sub-
cutaneous (ectopic) tumor graft models in nude mice,
do not sufficiently represent clinical cancer, particularly
with regard to metastasis formation, since the subcuta-
neous micro-environment for visceral tumors is consid-
erably different from their original environment [1,2].
Experimental liver metastasis can be induced by intras-
plenic [3] or direct intraportal [4] injection of cancer
cells in the nude mice; however, a major disadvantage of
this procedure is that the early stages of metastasis for-
mation, such as local invasion at the site of the primary
tumor and gaining access to lymphatics or blood vessels,
are bypassed [5]. Hence, to reproduce clinically relevant
spontaneous tumor metastasis, tumor cells should be
implanted into the correct anatomical (orthotopic) sites
of immunodeficient mice. However, this animal model
has a drawback - poor predictability of spontaneous me-
tastasis formation from the orthotopic primary tumor.
These tumor cells have sometimes been labeled with
fluorescent [6,7] or bioluminescent [8,9] reporter genes to
enable specific detection, but the poor penetration of light
within the mammalian tissue limits the use of fluorescent
and bioluminescent imaging to superficial lesions. Detect-
ing a metastatic tumor in the mouse liver at any level
deeper than 1 cm would be extremely difficult using fluor-
escent and bioluminescent imaging because approximately
90% of optical signal flux is lost per centimeter of mam-
malian tissue [10]. Moreover, cells expressing fluorescent
proteins remain detectable even after the cells die, which
may prevent from assessing therapeutic response of the
metastatic tumor.
To overcome this drawback, labeling tumor cells with
radionuclide reporter genes appears to be ideal since
their reporter products can be quantitatively and three-
dimensionally imaged even deep within the body using
corresponding radiolabeled reporter probes and positron
emission tomography or single-photon emission com-
puted tomography (SPECT). Among several radio-
nuclide reporter genes proposed to date, the human
sodium/iodide symporter (NIS) reporter gene appears to
be the most promising [11]. Nevertheless, there has been
no report to date on the application of the NIS reporter
gene for such metastatic cell tracking, and there is no
guarantee that it would be effective. It is unclear how
in vivo tumor growth can be delayed by the NIS gene
transfer despite the additional constitutive production of
reporter products, which often leads to a slower rate of
tumor growth than in the wild type. It is also unclear
how much metastatic potential is maintained in implanted
tumor cells transferred with the NIS gene because intra-
cellular levels of sodium ions as well as iodide may beincreased in such cells, and this may affect the complex
steps involved in the formation of metastases. In the
present study, we therefore aimed to develop a mouse
spontaneous liver metastasis model from an orthotopically
implanted human colon cancer cell line stably expressing
NIS reporter gene and to demonstrate the feasibility of




Vector construction, cell culture, stable gene transfer, and
selection
A human NIS cDNA [GenBank:NM000453] was synthe-
sized by polymerase chain reaction and cloned into the
EcoRI site of the multicloning site of pcDNA3 vector
(Invitrogen, Carlsbad, CA, USA) (pcDNA3-NIS) [12].
The human colon cancer cell line HCT116 (American
Type Culture Collection, Manassas, VA, USA) was used
in this study since it has been reported to have the
highest metastatic potential among the ten human
gastrointestinal cancer cell lines that have been studied
[3]. The cells were cultured in DMEM/F-12 (Invitrogen)
supplemented with 10% fetal bovine serum, 100-IU/ml
penicillin, and 50-μg/ml streptomycin. For stable gene
transfer, HCT116 cells were transfected with pcDNA3-
NIS by the calcium phosphate coprecipitation method
(pH 7.12) as previously described in [13]. For the selec-
tion, the cells were cultured in the presence of 1,000-μg/
ml G418 (Invitrogen). Approximately 80 drug-resistant
colonies were isolated and subcloned; three of these were
expanded for further analyses (cell lines A, B, and C),
where a non-transfected HCT116 cell line served as the
negative control (cell line N).
Western blotting
NIS protein expression in both stable and negative con-
trol cell lines was examined by Western blotting as pre-
viously described in [14]. Briefly, the membrane protein
fraction extracted from the cell lysates was assayed using
a mouse monoclonal anti-human NIS antibody (clone
FP5A; Lab Vision, Fremont, CA, USA) at 1:2,000 dilu-
tion. When NIS protein expression was detected by
Western blot, NIS protein levels were quantitatively
determined from the optical density measurements and
normalized to α-tubulin protein levels.
In vitro 99mTcO4
− uptake assay
The function of NIS protein in both stable and negative
control cell lines was confirmed by 99mTcO4
− uptake
assay as previously described in [15]. Briefly, 24 h after
seeding at 5 × 104 cells/well on 24-well plates, the cells
were incubated with a medium containing 3.7 kBq/well
of 99mTcO4
− for 30 min, washed gently and quickly twice
with ice-cold HBSS after removing the medium, and
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uptake levels were measured in terms of radioactivity in
the cell lysates relative to the total radioactivity added
and represented as a percentage. Furthermore, inhibition
of 99mTcO4
− uptake was confirmed using 50-μM sodium
perchlorate, a competitive inhibitor of NIS. These experi-
ments were performed in quadruplicate and repeated
twice.
Animals
Seven-week-old female nude mice (BALB/c A Jcl-nu/nu;
CLEA Japan, Tokyo, Japan) were used in all animal
experiments. All animals were humanely treated in
accordance with the Guide for the Care and Use of
Laboratory Animals formulated by the US National
Research Council [16]. Mice were fed a commercial diet
MB-1 (Funabashi farm, Funabashi, Japan) that was not
supplemented with iodine. The study was conducted in
accordance with our institutional Guide for the Care
and Use of Laboratory Animals (publication no. 7–35,
revised in 2011).
Small animal SPECT/CT imaging protocol
The small-animal SPECT/CT system FX (Gamma Med-
ica-Ideas, Northridge, CA, USA) was used along with
the pinhole collimator PH10 (Gamma Medica-Ideas).
Mice were anesthetized with 1% to 2% isoflurane and
heated by a lamp to maintain body temperature during
the entire scanning period. CT images were obtained for
anatomical orientation immediately before SPECT im-
aging. For SPECT imaging, 30 min after intravenous in-
jection of 111 MBq of 99mTcO4
− (Fujifilm RI Pharma,
Tokyo, Japan), 64 projections were acquired for 1 min
per projection at the shortest radius of rotation
(30 mm) in a 140 keV± 10% energy window. SPECT
images were reconstructed using ordered subset ex-
pectation maximization (5 iterations, 4 subsets) with-
out attenuation correction using the FLEX SPECT
software (Gamma Medica-Ideas). The reconstructed
images were consistent with 80 × 80 image matrices
and had a spatial resolution of 0.8 mm. For quantita-
tive analysis, a spherical region of interest was placed
so that a focal 99mTcO4
− uptake to the tumor was en-
tirely covered, and in vivo 99mTcO4
− uptake levels were
estimated as standardized uptake value (SUV) using a
cross-calibration factor measured in advance with a cy-
lindrical phantom and assuming a tissue specific grav-
ity of 1 g/ml.
In vivo studies using mouse subcutaneous xenograft
model
Three stable and one negative control cell lines were
harvested by trypsinization and washed three times with
cold serum-free medium. The four types of cellsuspension (3 × 106 cells/0.2 ml) were subcutaneously
injected in a rotating order in both shoulders and thighs
of the 15 mice, and each subcutaneous xenograft was
assessed separately.
To evaluate whether NIS transfer affected in vivo
tumor growth, xenograft growth was assessed by calli-
pering the maximum body surface diameter every 2 to
3 days for up to 2 months. The rate of tumor formation
was calculated for each cell line as the number of
tumors having diameter ≥8 mm divided by the number
of subcutaneous injection sites (n= 15). The threshold
diameter of the tumor formation was set to 8 mm be-
cause the tumor shrinkage and disappearance had been
recorded in tumors having diameter <8 mm. The mean
time to 8-mm tumor formation was also determined ex-
cluding tumors which failed to grow up to 8 mm within
8 weeks.
To confirm whether the functional characteristics of
99mTcO4
− uptake were preserved in vivo, SPECT/CT im-
aging was performed in the subcutaneous xenograft
model mice whenever each diameter of the four xeno-
grafts reached 8 mm.
In vivo studies using mouse orthotopic xenograft model
Cells (3 × 106) from one of the stable cell lines and the
negative control cell line were each subcutaneously
injected in the thigh of 15 nude mice. When the diameter
of the xenografts reached 10 mm, they were excised, cut
into small fragments (25 to 30 mg), and orthotopically
implanted into the cecal walls of another 15 nude mice
for each cell line, as previously described in [17].
During follow-up, the experimental endpoint was
defined as the detection of metastasis on SPECT/CT im-
aging and the humane endpoints as the heavy primary
tumor burden, paraneoplastic conditions (e.g., weight
loss >20%, respiratory difficulties), and pain/discomfort
because of tissue destruction or distension. Mice were
euthanized at the earliest endpoint.
SPECT/CT imaging was initiated 8 weeks after ortho-
topic implantation since some mice appeared to have
reached the humane endpoints around this time point.
Imaging was repeated every 1 to 2 weeks for as long as
possible.
Pathological necropsy
Complete necropsy was performed after euthanasia in
all mice in the orthotopic xenograft model. The cervical,
thoracic, abdominal, and pelvic organs were extracted en
bloc and sectioned in case of the need for microscopic
assessment of tumor tissue. The liver was entirely sec-
tioned at 2-mm thickness, and metastatic foci were
searched thoroughly by macroscopic inspection and pal-
pation of the sections so that all metastatic foci larger
than 1 mm could be detected.
Figure 1 In vitro studies. (A) Western blot of NIS protein, (B) NIS
protein levels normalized to α-tubulin protein levels, and (C) in vitro
99mTcO4
− uptake assay. Cell lines A, B, and C (black bars) were
HCT116 stably transfected with pcDNA3-NIS, and cell line N (white
bar) was the untransfected negative control. ND, not detectable.
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Tumor specimens were dissected, fixed in formalin,
embedded in paraffin, cut into 4-μm sections, immunos-
tained with primary mouse monoclonal anti-human NIS
antibody (clone FP5A; Lab Vision) at 1:100 dilution and
secondary anti-mouse immunoglobulin/horseradish per-
oxidase, and stained brown with 3,3 0-diaminobenzidine
HCl according to the manufacturer’s instructions. The
nuclei were stained with Mayer’s hematoxylin.
Statistical analysis
Data are presented as mean± SD. Two-way repeated
measure ANOVA with post hoc Bonferroni test was
used to compare mean values among three or four
groups. Unpaired Student’s t-test was used to compare
mean values between two groups. In Chi-square test, a
contingency table was used to compare rates or ratios
between two to four groups. The Kaplan-Meier method
was used to generate survival curves, and the log-rank
(Mantel-Cox) test was used to compare the survival
curves. All statistical analyses were performed using
Prism 5 for Mac OS X (GraphPad Software, La Jolla,




NIS protein was recognized at approximately 97 kDa
on Western blots from the three selected stable cell
lines A, B, and C, but not from the negative control
cell line N (Figure 1A,B). The wide bands for NIS
protein were probably attributable to the preparation
method from the membrane fraction, as previously
reported in [18]. The ratio of NIS protein levels to
α-tubulin protein levels was 1.82 in line A, 2.71 in




− uptake assay demonstrated high uptake
levels of 99mTcO4
− by all three stable cell lines (A:
27.50 ± 2.58%, B: 29.68 ± 5.07%, C: 33.02 ± 4.52%), but
not by the negative control cell line (N: 0.03 ± 0.01%)
(Figure 1C). The high 99mTcO4
− uptake levels were
almost completely inhibited by sodium perchlorate (A:
0.09 ± 0.03%, B: 0.08 ± 0.04%, C: 0.08 ± 0.05%).
In vivo studies using mouse subcutaneous xenograft
model
In vivo tumor growth was assessed in the subcutaneous
xenograft model mice. No significant difference was
observed in the rate of tumor formation among the four
cell lines (N: 93%, A: 80%, B: 73%, C: 93%) (Figure 2A).
The time to formation of tumors ≥8 mm in the three
stable cell lines (A: 40 ± 11 days, B: 27 ± 12 days, C:25 ± 10 days) was slightly greater than that in the nega-
tive control cell line (N: 21 ± 16 days). A statistically sig-
nificant difference was observed only between cell lines
A and N (p < 0.05, Figure 2B).
SPECT/CT imaging revealed intense 99mTcO4
− uptake
by the subcutaneous xenografts generated from cell
lines A, B, and C, but not by those generated from
cell line N (Figure 2C). The background levels of
99mTcO4
− were consistently low except for the physio-
logical uptake by the salivary glands, thyroid gland,
stomach, and urinary bladder. To minimize the effect
of tumor size, quantitative uptake analysis was per-
formed for tumors having diameter 8 to 13 mm
(n= 11 to 14/cell line). 99mTcO4
− uptake levels were sig-
nificantly higher in the subcutaneous xenografts
Figure 2 In vivo studies using mouse subcutaneous xenograft
model. (A) Rate of tumor formation, (B) time to tumor formation,
(C) SPECT/CT images of a representative mouse. SG, Th, St, and Bl
(arrowheads) indicate the salivary glands, thyroid, stomach, and
urinary bladder, respectively. Lt, left; MIP, maximum intensity
projection; Rt, right. (D) 99mTcO4
− uptake levels of subcutaneous
xenografts. Cell lines A, B, and C (black bars, arrows) were HCT116
stably transfected with pcDNA3-NIS, and cell line N (white bar,
arrow) was the untransfected negative control.
Figure 3 SPECT/CT fusion images and the liver surface. (A)
Transaxial and (B),(C) coronal sections of SPECT/CT fusion images
and (D) macroscopic view of the liver surface of a representative
mouse orthotopically implanted with a line B tumor fragment. Focal
99mTcO4
− uptake (white arrows; SUV= 5.71) on SPECT/CT images
corresponds to tumor cell infiltration (black arrow) in the
macroscopic view. Th, Stom, Ortho, Perito, and Blad (arrowheads)
indicate the thyroid, stomach, orthotopically implanted primary
tumor, peritoneal dissemination, and bladder, respectively. Lt, left; Rt,
right.
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(6.1 ± 2.2) than in those generated from cell lines C
(2.0 ± 1.0) and N (0.5 ± 0.2) (p < 0.001, Figure 2D).Based on the results of these experiments conducted
using subcutaneous xenograft model mice, we decided
to use cell line B, which showed both rapid tumor
growth and high in vivo 99mTcO4
− uptake levels (11.8-fold
of line N), from the three stable cell lines for generating
mouse orthotopic xenograft model.
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In all 15 mice implanted with line B tumor fragments,
SPECT/CT imaging was performed one to three times
per mouse until the experimental or humane endpoint.
A focal 99mTcO4
− uptake was found in the right lower
abdomen of 12 (80%) of the 15 mice, which corre-
sponded to the orthotopic xenograft. Faint and intermit-
tent 99mTcO4
− uptakes along the abdominal wall were
also observed in the same 12 mice, which were specu-
lated to be uptake to the peritoneal dissemination of the
cancer cells (Figure 3C). Furthermore, in three (20%) of
these 12 mice, focal 99mTcO4
− uptakes were detected in
the liver, which were estimated to be liver metastases, al-
though none of them were detected on CT images. The
maximum SUV of the focal uptakes in the liver was
5.71, 4.75, and 2.21 (Figure 3A,B). In contrast, the
remaining three mice (20%) did not display any abnor-
mal uptake of 99mTcO4
− in the abdomen, which were
judged as engrafting failures.
On the other hand, in 12 of the 15 mice implanted
with line N negative control tumor fragments, SPECT/
CT images were obtained only once, and no abnormal
99mTcO4
− uptake was observed. The remaining three
negative control mice reached a humane endpoint
and were thus euthanized before SPECT/CT imaging.
The mice with cell line N tumor fragments reached
humane endpoints faster than those with line B
tumor fragments, and all the mice were euthanized at
9 weeks after implantation (Figure 4).
Pathological necropsy
In the three mice implanted with line B tumor fragments
and euthanized because of the absence of physical signs of
tumor development, pathological necropsy demonstrated
that the fragments had not been taken up at the orthoto-
pic sites. In the remaining 27 mice, the orthotopicallyFigure 4 Survival curves. Of mice orthotopically implanted with
line B tumor fragments (n= 12) and those implanted with line N
negative control fragments (n= 15). Three mice implanted with line
B tumor fragments and euthanized because of the absence of
physical signs of tumor development were excluded from this
analysis. Median survival times were 75 days for line B and 55 days
for line N (p< 0.0001).implanted tumors resulted in local growth with extensive
invasion as well as microscopic serosal metastasis.
The severe peritoneal adhesion hampered abdominal tis-
sue collection for biodistribution of 99mTcO4
− after in vivo
systemic administration.
Many white dots (approximately 100 μm) indicating
small metastases were macroscopically observed on the
peritoneum and the surface of the liver, but they were
below the detectable size by SPECT/CT imaging. We
believe that all metastatic foci larger than 1 mm (ap-
proximately 1 to 2 mm) were detected by the thorough
pathological investigation of the liver metastases. Three
foci found in mice with line B fragments (approximately
2 to 5 mm) corresponded to the focal 99mTcO4
− uptake
on SPECT/CT images (Figure 3D). Other four meta-
static foci found by pathological necropsy were in the
mice with negative control fragments. No apparent
metastases were detected at other sites such as the
lungs and regional lymph nodes.
Immunohistochemistry
Immunohistochemical staining of the liver tumor tissue
from the mice orthotopically implanted with line B
tumor fragments revealed high levels of NIS expression
in cells forming the liver tumor except the intratumoral
necrotic regions (Figure 5). Since NIS proteins were con-
stitutively produced in the cytoplasm and then moved to
the membrane, the entire cytoplasm as well as the mem-
brane was stained brown, but they could not be discri-
minated. In contrast, no NIS expression was observed in
the liver tumor cells of mice implanted with negative
control tumor fragments. These findings confirm that
the liver tumor cells originated from the orthotopic
colon xenografts.
Discussion
In the in vitro experiments, we established three stable
cell lines from three single cells transduced with NIS
reporter gene and confirmed the production and func-
tion of NIS protein by Western blotting and 99mTcO4
−
uptake assay. In the following in vivo studies using the
mouse subcutaneous xenograft model, we found signifi-
cant growth delay in line A compared with line N. It is a
common phenomenon that compared with nontrans-
ferred cells, growth delay is observed in cells stably
transduced with an exogenous gene driven by a constitu-
tive promoter, probably because gene-transferred cells
shoulder the burden of continuously producing its add-
itional protein. In addition, in vivo 99mTcO4
− uptake
levels of xenografts were not consistent with their
in vitro 99mTcO4
− uptake levels because various host fac-
tors such as vascularity and local immunity might have
affected 99mTcO4
− uptake in vivo. Our results indicated
that compared with the original cell line, the growth
Figure 5 Immunohistochemistry. Demonstrating NIS in the liver
tumor tissue of representative mice implanted with a line B tumor
fragment (A and C) and a line N negative control fragment (B and
D). Areas bordered by dotted lines indicate the liver tumors. High
levels of NIS expression were observed in cells (black arrows)
forming the liver tumor except for intratumoral necrotic regions (red
arrow) of the mice with line B tumor fragments, but no NIS
expression was observed in the tumor cells (white arrows) in the
liver of mice implanted with line N fragments.
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lines B and C and that in vivo 99mTcO4
− uptake to xeno-
grafts was preserved in lines A and B. Finally, in the
in vivo studies using the mouse orthotopic xenograft
model with line B, we, for the first time, succeeded in
tomographic visualization and quantitative assessment
of the clinically relevant spontaneous liver metastases
from the colon cancer in living mice. The metastatic po-
tential to the liver from the orthotopic tumor made with
line B (3/12 mice = 25%) was comparable to that made
with the control line N (4/15 mice = 26.7%). The time to
metastatic formation and death was prolonged in the
mice implanted with line B compared with those with
line N. This dissociation might be related to the fact that
the time to tumor formation of cell line B tended to be
longer than that of cell line N. However, it will not be a
critical problem because the median survival times were
within the reported range of 1 to 4 months in both
groups [19] and also because in future applications line
B mice with intervention (e.g., novel therapy) will be
compared with line B mice without intervention instead
of line N mice.
The most common way to perform these experiments is
to employ a lentiviral construct under conditions of nearly
100% transduction efficiency or to use a bicistronic con-
struct encoding both a radionuclide reporter gene and afluorescent reporter gene such as GFP to select a trans-
duced population of cells using a fluorescence-activated
cell sorter. However, neither of the transduction effi-
ciency or the selection specificity is expected to be
completely 100%. Accordingly, if one uses such a
polyclonal population of NIS-transduced cells in a
similar study, it would be speculated that a small
population of cancer cells not transduced with a
reporter gene will gradually increase in the primary
tumor and may dominantly form metastases, since
non-transduced cells are generally faster in tumor
growth and metastatic formation compared with
transduced cells as shown in our study as well. Also,
it would be feared that individual variations become
larger among animals, since tumor growth and
in vivo 99mTcO4
− uptake levels vary among clones of
NIS-transduced cells as demonstrated in our study. In
contrast, we used a clone from a single cell trans-
duced with the reporter gene to assure that all cells
were transduced with NIS reporter gene and had
homogeneous characteristics, which we believe was
the key advantage in the current study.
In addition, using SPECT, we succeeded in clearly visu-
alizing and quantitatively assessing focal 99mTcO4
− uptake
in the liver tumors of mice orthotopically implanted with
NIS-expressing colon cancer fragments. We also demon-
strated, as the in vivo proof of concept, by pathological
necropsy and NIS immunohistochemistry that these were
spontaneous liver metastases from the orthotopic colon
xenografts. Several recent studies have applied spontan-
eous metastasis models to breast cancer, melanoma, lung
cancer, and colon cancer, although not by labeling
with reporter genes to test new therapeutic regimens be-
cause conventional subcutaneous primary tumor xeno-
graft models are often poorly predictive of the therapeutic
effects of new drugs [20]. One previous study using a
spontaneous metastasis model for breast cancer reported
that orthotopic primary tumors significantly responded to
trastuzumab monotherapy, whereas minimal antitumor
effect was observed when mice with metastatic disease
were treated [21]. In contrast, another study reported that
a combination of 5-fluorouracil prodrug and cyclophos-
phamide showed striking therapeutic effects on advanced
spontaneous metastatic disease, but not on the primary
orthotopic breast tumors [22]. These discrepancies sug-
gest that anticancer drug activity requires evaluation in an
appropriate metastasis model for the development and
assessment of new therapeutic regimens. As spontaneous
metastasis models reproduce all the events involved in the
multistep process of the metastatic cascade, they should
also help to improve our understanding of the mechan-
isms that regulate metastatic spread and growth [20].
In spite of the advantage of using spontaneous metas-
tasis models, certain challenges associated with the
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[20]. First, although they argued for the surgical removal
of orthotopic primary tumors of lung cancer or melan-
oma at a considerable size (400 to 500 mm3) to prevent
the rapidly growing primary tumors from causing end-
point termination of the experiment, tumors may grow
asynchronously making it difficult to decide when sur-
gery should be performed. Second, spontaneous metasta-
ses appear unevenly over the experimental time course,
although such complexity may hold an advantage in that
individual differences in metastatic patterns are more real-
istic and reflective of the clinical presentation of metasta-
ses. Our approach to tomographically visualize both of
the primary and metastatic tumors by stably transfer-
ring the NIS reporter gene into tumor cells will add a
practical aspect to spontaneous metastasis models
with regard to solving these issues.
Finally, the present study still has a potential limita-
tion. We found spontaneous liver metastases developed
in only three (25%) of 12 mice with local invasion of the
reporter fragments. The metastatic rate was relatively
low compared with the level of 47% to 60% as reported
in previous studies using HCT116 cell lines [19,23,24].
The major obstacle in our study related to this discrep-
ancy seemed to be difficulty due to the severe peritoneal
adhesion in resecting the orthotopically implanted pri-
mary colon tumor to interrupt the rapid growth, and in
fact, 12 of the 15 mice with the reporter tumor frag-
ments had to be euthanized at the humane endpoints
rather than the experimental endpoint. Thus, another
cell line with a slower growth rate (e.g., cell line A)
might be used preferably for slower progression of pri-
mary tumors only if it preserves high metastatic poten-
tial. Alternatively, the metastatic potential of the given
cancer cells should be reinforced by serial in vivo selec-
tion to facilitate metastasis formation. A previous report
described that 4 cycles of selection yielded their cell lines
with a very high metastatic efficiency [25]. We are plan-
ning to address this limitation in the future; however, for
the time being, this limitation could be offset by per-
forming the experiment with more number of mice per
group.
Conclusion
Despite the need for improvement in the efficiency of
metastasis formation, the current proof-of-concept
study provided a rationale for applying a radionuclide
reporter gene for the specific visualization of spontan-
eous liver metastasis in living mice. Compared with
the previous methods utilizing fluorescent or bio-
luminescent reporter genes, our approach utilized a
fully 3D modality with high quantitative accuracy and
high sensitivity particularly deep within the body. This
unique animal model of clinically relevant andexternally detectable liver metastasis will be a power-
ful tool for investigating tumor biology and develop-
ing novel therapies for human colon cancer
metastasis.
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